XHKG2155
Market cap595mUSD
Dec 23, Last price
3.96HKD
1D
-1.00%
1Q
-16.98%
IPO
-49.10%
Name
Morimatsu International Holdings Co Ltd
Chart & Performance
P/E
5.14
P/S
0.59
EPS
0.72
Div Yield, %
0.00%
Shrs. gr., 5y
4.61%
Rev. gr., 5y
24.43%
Revenues
7.36b
+13.47%
Net income
845m
+26.21%
CFO
671m
-25.84%
Dividend
Jul 03, 20240.1 HKD/sh
Earnings
Jun 18, 2025
Profile
Morimatsu International Holdings Company Limited designs, manufactures, installs, and operates and maintains process equipment, process systems, and solutions primarily for chemical, biological, and polymerization reactions in China and internationally. The company's pressure equipment primarily includes heat exchangers, tanks, reactors, and towers. It offers bioreactor systems and fermenters, parallel bioreactor systems, culture medium, pharmaceutical solutions, online solution preparation systems, harvest systems, buffer solution preparation and storage system, inactivation and CIP workstation systems, isolators, disposable magnetic mixing systems, disposable solution storage and mixing systems, modular factory, and clean decorators, as well as disposable magnetic mixing systems and wave reactors. The company also provides design, verification, maintenance, digital operation and maintenance, and other related services. It offers its services to oil and gas, new chemical materials, pharmaceuticals, raw materials for power batteries, water treatment, new energy, consumer goods, electronic chemicals, and other industries. Morimatsu International Holdings Company Limited was founded in 1990 and is headquartered in Shanghai, China.
IPO date
Mar 15, 2021
Employees
4,000
Domiciled in
CN
Incorporated in
HK
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|
| 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | |
| Income | |||||||
Revenues | 7,360,262 13.47% | 6,486,277 51.59% | 4,278,847 43.65% | ||||
Cost of revenue | 6,441,078 | 5,703,883 | 3,810,231 | ||||
Unusual Expense (Income) | |||||||
NOPBT | 919,184 | 782,394 | 468,616 | ||||
NOPBT Margin | 12.49% | 12.06% | 10.95% | ||||
Operating Taxes | 141,786 | 94,735 | 67,272 | ||||
Tax Rate | 15.43% | 12.11% | 14.36% | ||||
NOPAT | 777,398 | 687,659 | 401,344 | ||||
Net income | 844,684 26.21% | 669,266 75.27% | 381,838 31.95% | ||||
Dividends | (30,000) | ||||||
Dividend yield | 0.33% | ||||||
Proceeds from repurchase of equity | 601,263 | 1,000 | 571,596 | ||||
BB yield | -8.73% | 0.00% | -6.23% | ||||
| Debt | |||||||
Debt current | 189,836 | 260,658 | 372,340 | ||||
Long-term debt | 213,747 | 229,901 | 5,410 | ||||
Deferred revenue | 44,364 | 42,434 | 353 | ||||
Other long-term liabilities | |||||||
Net debt | (1,957,137) | (915,971) | (1,178,207) | ||||
| Cash flow | |||||||
Cash from operating activities | 671,276 | 905,146 | 1,173,718 | ||||
CAPEX | (570,779) | (867,054) | (443,462) | ||||
Cash from investing activities | (408,130) | (1,148,701) | (448,131) | ||||
Cash from financing activities | 506,975 | 57,050 | 445,058 | ||||
FCF | 272,572 | 43,187 | 53,406 | ||||
| Balance | |||||||
Cash | 2,227,831 | 1,624,107 | 1,545,774 | ||||
Long term investments | 132,889 | (217,577) | 10,183 | ||||
Excess cash | 1,992,707 | 1,082,216 | 1,342,015 | ||||
Stockholders' equity | 4,429,553 | 2,817,056 | 1,969,938 | ||||
Invested Capital | 2,826,599 | 2,181,793 | 1,006,652 | ||||
ROIC | 31.04% | 43.13% | 36.99% | ||||
ROCE | 18.95% | 23.90% | 19.92% | ||||
| EV | |||||||
Common stock shares outstanding | 1,252,495 | 1,156,099 | 1,004,396 | ||||
Price | 5.50 -36.56% | 8.67 -5.14% | 9.14 | ||||
Market cap | 6,888,722 -31.27% | 10,023,378 9.18% | 9,180,179 | ||||
EV | 4,939,704 | 9,114,323 | 8,001,972 | ||||
EBITDA | 1,064,625 | 896,208 | 561,545 | ||||
EV/EBITDA | 4.64 | 10.17 | 14.25 | ||||
Interest | 13,291 | 15,951 | 22,789 | ||||
Interest/NOPBT | 1.45% | 2.04% | 4.86% | ||||